![](/img/cover-not-exists.png)
Phase 1 Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
Baumeister, Susanne H., Murad, Joana, Werner, Lillian, Daley, Heather, Trebeden-Negre, Helene, Gicobi, Joanina K, Schmucker, Adam, Reder, Jake, Sentman, Charles L, Gilham, David Edward, Lehmann, FrédéLanguage:
english
Journal:
Cancer Immunology Research
DOI:
10.1158/2326-6066.CIR-18-0307
Date:
November, 2018
File:
PDF, 2.78 MB
english, 2018